Peer-reviewedCC BY 4.0Cell Reports
An engineered probiotic for diagnosis and mucosal healing in inflammatory bowel disease
Related
- Engineered living materials suppress uropathogenic E. coli growth and invasion of urothelial cells through sustained probiotic release
- Targeted tumor desialylation by engineered probiotic reprograms the tumor microenvironment to potentiate immunotherapy
- Engineered probiotic-mediated palmitoylethanolamide biosynthesis protects against colitis-associated liver injury
- Baseline mucosal transcriptomic endotypes stratify healing capacity and biologic therapy outcomes in ulcerative colitis: an integrative multi-cohort study
- Commensal Engineered Living Materials for Sustained Secretome Delivery and Wound Healing
BibTeX
@article{zhao2026engineered,
title = {{An engineered probiotic for diagnosis and mucosal healing in inflammatory bowel disease}},
author = {Yu Zhao and Yujie Sun and Xiaofeng Zhu and Wulong Hu and Sifeng Chen and Guofan Peng and Shichao Yang and Ding Ma and Xiayu Mao and Shengen Yi and Li Tian and Kang Han and Xiongzhuo Tang and Jin Hai Zheng and Jun Zhou},
journal = {Cell Reports},
year = {2026},
month = oct,
doi = {10.1016/j.celrep.2026.118171},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2211124726012507},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - An engineered probiotic for diagnosis and mucosal healing in inflammatory bowel disease
AU - Yu Zhao
AU - Yujie Sun
AU - Xiaofeng Zhu
AU - Wulong Hu
AU - Sifeng Chen
AU - Guofan Peng
AU - Shichao Yang
AU - Ding Ma
AU - Xiayu Mao
AU - Shengen Yi
AU - Li Tian
AU - Kang Han
AU - Xiongzhuo Tang
AU - Jin Hai Zheng
AU - Jun Zhou
PY - 2026
DA - 2026/10/30
JO - Cell Reports
DO - 10.1016/j.celrep.2026.118171
UR - https://linkinghub.elsevier.com/retrieve/pii/S2211124726012507
SN - 2211-1247
ER -